SymBiosis Capital Partners, LLC SEC EDGAR Filings (CIK 0002006045)

SEC EDGAR filings, ownership reports, and insider transactions for SymBiosis Capital Partners, LLC.

Business address
609 Sw 8 Th St, Suite 510, Bentonville, AR, 72712
Top securities (13F)
EVMN, VSTM, PGEN, IVA, NUVB, RANI, AARD, CLNN, GBIO, and SRZNW
Top holdings (Schedule 13G)
GBIO and Rani Therapeutics Holdings, Inc.
State of incorporation
DE
Fiscal year end
31 December
SymBiosis Capital Partners, LLC has filed 6 SEC EDGAR filings since 14 Nov 2025

Latest Filings

Recent SEC filings for SymBiosis Capital Partners, LLC including SCHEDULE 13G, 13F-HR, 144 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Feb 2026
13F-HR Open 13F-HR document View SEC filing for 13F-HR 12 Feb 2026 31 Dec 2025 028-26251
144 Open 144 document View SEC filing for 144 03 Feb 2026
144 Open 144 document View SEC filing for 144 05 Dec 2025
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 Nov 2025
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Nov 2025

About this filer

SymBiosis Capital Partners, LLC files with the SEC under CIK 0002006045. This page aggregates EDGAR filings and related ownership activity.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages